Patient-reported financial toxicity and adverse medical consequences in head and neck cancer.

ABSTRACT:

Objectives

Financial toxicity (FT) is a significant barrier to high-quality cancer care, and patients with head and neck cancer (HNCA) are particularly vulnerable given their need for intensive support, daily radiotherapy (RT), and management of long-term physical, functional, and psychosocial morbidities following treatment. We aim to identify predictors of FT and adverse consequences in HNCA following RT.

Materials and methods

We performed a prospective survey study of patients with HNCA seen in follow-up at an academic comprehensive cancer center (CCC) or Veterans Affairs hospital between 05/2016 and 06/2018. Surveys included validated patient-reported functional outcomes and the COST measure, a validated instrument for measuring FT.

Results

The response rate was 8

SUBMITTER: Beeler WH 

PROVIDER: S-EPMC7008081 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature